NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Advanced cancer histologies for which immune checkpoint blockade is an approved treatment option, such as: Metastatic melanoma, Lung cancer, Renal Cell Carcinoma (RCC), Hodgkin’s lymphoma, Microsatellite Instability (MSI)-high colon cancer, Hepatocellular Carcinoma (HCC), and Gastric cancer.
1 total trials1 recruiting
Filter these 1 trials by phase, country, sponsor and more.